53 stories
IPO implications?
HubSpot's head of product and VP of engineering will depart in September
HubSpot chief product officer David Cancel, in one of the Cambridge company's conference rooms. Photo by Scott Kirsner / BetaBoston.
Big news being announced this afternoon at HubSpot, the digital marketing startup widely regarded to be on the verge of an initial public offering: David Cancel, the Cambridge company's chief product officer, plans to leave in September, along with Elias Torres, an engineering vice president. The duo joined HubSpot in 2011, when HubSpot paid $20 million for their 20-person startup, Performable, in its biggest acquisition to date. Read More
Exuberance interrupted
IPO window shuts for two Massachusetts biotech companies
(Map graphic courtesy of Boston.com)

Ten Massachusetts biotech companies have gone public so far in 2014, a record number for any one year. But the next two contenders in line— who were expected to complete initial public offerings this week — did not make it through the IPO window amid an apparent glut of biotech IPO supply nationally.

Read More